Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 04-2017 | 01-2017 | 10-2016 | 07-2016 | 04-2016 | |
| Sales | 3,719 | 3,565 | 4,457 | 3,670 | 2,837 |
| Cost of Goods | 2,571 | 2,406 | 2,203 | 2,523 | 2,296 |
| Gross Profit | 1,148 | 1,159 | 2,254 | 1,147 | 541 |
| Operating Expenses | 4,111 | 2,966 | 2,950 | 4,193 | 3,390 |
| Operating Income | -2,392 | -1,401 | -493 | -2,523 | -2,553 |
| Other Income | -23 | -8 | -16 | -9 | -6 |
| Pre-tax Income | -2,415 | -1,409 | -509 | -2,532 | -2,559 |
| Income Tax | 10 | 0 | -5 | 14 | 14 |
| Net Income Continuous | -2,425 | -1,409 | -504 | -2,546 | -2,573 |
| Net Income | $-2,425 | $-1,409 | $-504 | $-2,546 | $-2,573 |
| EPS Basic Total Ops | -0.20 | -0.13 | -0.05 | -0.26 | -0.30 |
| EPS Basic Continuous Ops | -0.21 | -0.13 | -0.05 | -0.26 | -0.30 |
| EPS Diluted Total Ops | -0.20 | -0.13 | -0.05 | -0.26 | -0.30 |
| EPS Diluted Continuous Ops | -0.21 | -0.13 | -0.05 | -0.26 | -0.30 |
| EBITDA(a) | $-2,351 | $-1,361 | $-451 | $-2,478 | $-2,511 |